Scientific Sessions 2024  /  Featured Science: Vascular Outcomes in the Spotlight  /  Discussant: ONCO PE Trial
Logo

American Heart Association

  180
  0

Final ID:

Discussant: ONCO PE Trial

  • Kadian, Daniella  ( Mount Sinai , New York City , New York , United States )
  • Casanegra, Ana  ( MAYO CLINIC , Rochester , Minnesota , United States )
  • Okwuosa, Tochi  ( RUSH UNIVERSITY , Chicago , Illinois , United States )
    • Author Disclosures:
    Daniella Kadian: DO have relevant financial relationships ; Consultant:Boston Scientific:Active (exists now) ; Speaker:Medscape:Active (exists now) ; Speaker:Women As One:Past (completed) ; Executive Role:Society for Vascular Medicine:Active (exists now) ; Executive Role:CLI Global Society:Active (exists now) ; Research Funding (PI or named investigator):Philips Healthcare:Past (completed) ; Speaker:Abbott Laboratories:Active (exists now) | Ana Casanegra: DO NOT have relevant financial relationships | Tochi Okwuosa: DO have relevant financial relationships ; Consultant:ANTEV:Past (completed)
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

Session Info:

Featured Science: Vascular Outcomes in the Spotlight

Monday, 11/18/2024 , 08:00AM - 09:15AM

Featured Science

More abstracts on this topic:
Geographical variations of treatment disparities between Black and White patients with peripheral artery disease across the United States

Vogel Birgit, Erim Daniel, Pylypchuk Yuriy, Keever Rachel, Mehran Roxana, Dangas Katerina, Di Muro Francesca Maria, Sartori Samantha, Oliva Angelo, Dangas George, Krishnan Prakash, Yoon Harrison, Etter Katherine

Evolution of Novel Therapies in Vascular Medicine

Creager Mark, Beckman Joshua

More abstracts from these authors:
Genetics of FMD and SCAD: Where we are and where we need to go

Kovacic Jason, Saw Jacqueline, Ganesh Santhi, Kadian Daniella

Panelist 4

Kadian Daniella, Leleiko Rebecca

You have to be authorized to contact abstract author. Please, Login
Not Available